Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Journal of Liver Cancer ; : 129-133, 2016.
Artigo em Coreano | WPRIM | ID: wpr-76009

RESUMO

Liver cancer is the 2nd most common cause of cancer related death in Korea. Especially, patients who present extrahepatic spread of hepatocellular carcinoma (HCC) have a shorter life expectancy (50% survival at 1 year and less than 4 months of median overall survival). Molecular target agent like sorafenib was usually mentioned as a treatment for them, but that was still not firmly established. We present a 75 year-old who had expanding nodular type of HCC. The mass was removed by resection and radiofrequency ablation. However, lung metastasis were revealed shortly after surgery. That lesions were treated with lenvatinib and systemic chemotherapy.


Assuntos
Humanos , Carcinoma Hepatocelular , Ablação por Cateter , Tratamento Farmacológico , Coreia (Geográfico) , Expectativa de Vida , Neoplasias Hepáticas , Pulmão , Terapia de Alvo Molecular , Metástase Neoplásica
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA